Leadsynbio

Leadsynbio

Advancing sustainable bio-manufacturing with innovative enzyme engineering and metabolic solutions.

Founded 2015 Series D Total: $120.91M Biopharma, Biotechnology +2

Leadsynbio, founded in 2015, is a pioneering bio-manufacturing technology company that is making significant strides in the sustainable production of chemical products. The company's slogan "Advancing sustainable bio-manufacturing with innovative enzyme engineering and metabolic solutions" encapsulates its commitment to environmental responsibility and technological advancement. With a focus on biopharma, biotechnology, health care, and manufacturing industries, Leadsynbio is at the forefront of creating eco-friendly solutions and reducing pollution in heavy industries. Leadsynbio's core expertise lies in bio-catalytic synthesis processes, enzyme product development, and comprehensive production, sales, and technical services. The company also extends its support to downstream businesses through services such as enzyme engineering, strain modification, and metabolic engineering, offering outsourced technical and production expertise. In a significant development, Leadsynbio secured a Series D investment of $20.91M on 11 August 2023, with funding from prominent investors including Lilly Asia Ventures and Sherpa Venture Capital. This substantial investment attests to the confidence that industry leaders have in Leadsynbio's vision and potential for growth and impact in the bio-manufacturing sector. With this latest injection of capital, Leadsynbio is well-positioned to further advance its cutting-edge technologies and expand its reach in creating sustainable solutions for the industries it serves.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$20.91M	2	Lilly Asia Ventures, Sherpa Healthcare Partners	11 Aug 2023
Series C	CNY100.00M	8	Lilly Asia Ventures, GF Qianhe Investment +6	08 Feb 2022
Series C	Undisclosed	-		16 Dec 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$20.91M

Lilly Asia Ventures, Sherpa Healthcare Partners

11 Aug 2023

Series C

CNY100.00M

Lilly Asia Ventures, GF Qianhe Investment +6

08 Feb 2022

Series C

Undisclosed

16 Dec 2021

FAQ About Leadsynbio

Advancing sustainable bio-manufacturing with innovative enzyme engineering and metabolic solutions.

Leadsynbio was founded in 2015.

Leadsynbio operates in Biopharma, Biotechnology, Health Care and Manufacturing. Its work centres on bio-manufacturing, enzyme engineering, metabolic solutions and sustainable technology.

Leadsynbio has completed 3 funding rounds, raising a total of $120.91M. The latest funding stage is Series D.

Top alternatives and competitors to Leadsynbio include Biosyntia, Bestzyme, Manna, Bota Biosciences, Polylabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Leadsynbio and Biosyntia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Leadsynbio

Funding Rounds & Investors (3)

Leadsynbio Alternatives & Competitors

FAQ About Leadsynbio